NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-05-16
DOI
10.1038/s41401-018-0003-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined NADPH and the NOX inhibitor apocynin provides greater anti-inflammatory and neuroprotective effects in a mouse model of stroke
- (2017) Yuan-Yuan Qin et al. FREE RADICAL BIOLOGY AND MEDICINE
- What has passed is prolog: new cellular and physiological roles of G6PD
- (2016) Hung-Chi Yang et al. FREE RADICAL RESEARCH
- TRPM2 Promotes Neurotoxin MPP+/MPTP-Induced Cell Death
- (2016) Yuyang Sun et al. MOLECULAR NEUROBIOLOGY
- Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders
- (2016) Md. Torequl Islam NEUROLOGICAL RESEARCH
- β-Ecdysterone Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Apoptosis via Mitochondria-Dependent Mechanism: Involvement of p38MAPK–p53 Signaling Pathway
- (2016) Zhi Pan et al. NEUROTOXICITY RESEARCH
- Nephroprotective Effects of N-Acetylcysteine Amide against Contrast-Induced Nephropathy through Upregulating Thioredoxin-1, Inhibiting ASK1/p38MAPK Pathway, and Suppressing Oxidative Stress and Apoptosis in Rats
- (2016) Xuezhong Gong et al. Oxidative Medicine and Cellular Longevity
- N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data
- (2016) Daniel A. Monti et al. PLoS One
- Compromised MAPK signaling in human diseases: an update
- (2015) Eun Kyung Kim et al. ARCHIVES OF TOXICOLOGY
- Controlled Striatal DOPA Production From a Gene Delivery System in a Rodent Model of Parkinson's Disease
- (2015) Erik Cederfjäll et al. MOLECULAR THERAPY
- Ischemia/reperfusion-induced upregulation of TIGAR in brain is mediated by SP1 and modulated by ROS and hormones involved in glucose metabolism
- (2015) Meiling Sun et al. NEUROCHEMISTRY INTERNATIONAL
- Pathogenic Mechanisms of Neurodegeneration in Parkinson Disease
- (2015) Stephen Mullin et al. NEUROLOGIC CLINICS
- Reduced Nicotinamide Adenine Dinucleotide Phosphate, a Pentose Phosphate Pathway Product, Might Be a Novel Drug Candidate for Ischemic Stroke
- (2015) Mei Li et al. STROKE
- Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
- (2015) Brent J. Ryan et al. TRENDS IN BIOCHEMICAL SCIENCES
- The Role of Oxidative Stress in Neurodegenerative Diseases
- (2015) Geon Ha Kim et al. Experimental Neurobiology
- The role of malic enzyme as the provider of NADPH in oleaginous microorganisms: a reappraisal and unsolved problems
- (2014) Colin Ratledge BIOTECHNOLOGY LETTERS
- A TIGAR-Regulated Metabolic Pathway Is Critical for Protection of Brain Ischemia
- (2014) M. Li et al. JOURNAL OF NEUROSCIENCE
- Protective Effects of Salidroside in the MPTP/MPP+-Induced Model of Parkinson's Disease through ROS–NO-Related Mitochondrion Pathway
- (2014) Songhai Wang et al. MOLECULAR NEUROBIOLOGY
- Drug-induced parkinsonism
- (2013) José López-Sendón et al. Expert Opinion On Drug Safety
- TNFR1/TNF-α and mitochondria interrelated signaling pathway mediates quinocetone-induced apoptosis in HepG2 cells
- (2013) Chaoming Zhang et al. FOOD AND CHEMICAL TOXICOLOGY
- Glutathione metabolism and Parkinson's disease
- (2013) Michelle Smeyne et al. FREE RADICAL BIOLOGY AND MEDICINE
- Lysosomal dysfunction in Parkinson disease
- (2012) Benjamin Dehay et al. Autophagy
- Pyridine Nucleotide Regulation of Cardiac Intermediary Metabolism
- (2012) John R. Ussher et al. CIRCULATION RESEARCH
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
- (2012) David N. Hauser et al. NEUROBIOLOGY OF DISEASE
- Kinases and kinase signaling pathways: Potential therapeutic targets in Parkinson's disease
- (2012) Gang Wang et al. PROGRESS IN NEUROBIOLOGY
- Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond
- (2011) Celine Perier et al. ANTIOXIDANTS & REDOX SIGNALING
- Neuroprotective cytokines repress PUMA induction in the 1-methyl-4-phenylpyridinium (MPP+) model of Parkinson’s disease
- (2011) Yeon-Hee Kook et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Novel Role for Interleukin-27 (IL-27) as Mediator of Intestinal Epithelial Barrier Protection Mediated via Differential Signal Transducer and Activator of Transcription (STAT) Protein Signaling and Induction of Antibacterial and Anti-inflammatory Proteins
- (2011) Julia Diegelmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Motor complications in Parkinson's disease: Ten year follow-up study
- (2010) Iria Cabo López et al. MOVEMENT DISORDERS
- Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease
- (2009) G.E. Meredith et al. EXPERIMENTAL NEUROLOGY
- Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease
- (2009) I. Kurkowska-Jastrzębska et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mitochondrial kinases in Parkinson’s disease: Converging insights from neurotoxin and genetic models
- (2009) Ruben K. Dagda et al. MITOCHONDRION
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- (2009) K Wu et al. POSTGRADUATE MEDICAL JOURNAL
- The PINK1–Parkin pathway is involved in the regulation of mitochondrial remodeling process
- (2008) Jeehye Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glutathione and Parkinson's disease: Is this the elephant in the room?
- (2008) Gail D. Zeevalk et al. BIOMEDICINE & PHARMACOTHERAPY
- Selective Activation of p38 Mitogen-Activated Protein Kinase in Dopaminergic Neurons of Substantia Nigra Leads to Nuclear Translocation of p53 in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice
- (2008) S. Karunakaran et al. JOURNAL OF NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now